Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Regeneron Pharmaceuticals Inc., 3 years.
Regeneron Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 23, 2024 | Regeneron Pharmaceuticals Inc. | Option exercise | +2,707 | $625.60 | $1,693,499 |
| Jan 23, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −2,707 | $950.00 | $2,571,650 |
| Jan 2, 2024 | Regeneron Pharmaceuticals Inc. | Grant or award | +135 | — | — |
| Feb 6, 2023 | Regeneron Pharmaceuticals Inc. | Option exercise | +3,613 | $482.68 | $1,743,923 |
| Feb 6, 2023 | Regeneron Pharmaceuticals Inc. | Open-market sale | −3,613 | $800.00 | $2,890,400 |
| Jan 3, 2023 | Regeneron Pharmaceuticals Inc. | Grant or award | +165 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.